The sight of the MV Hondius sailing toward Tenerife’s Granadilla Port on May 9, 2026, triggered a visceral reaction among locals that had little to do with the ship itself and everything to do with a collective trauma. For many, the image of a cruise ship carrying an infectious outbreak was a haunting echo of 2020, reigniting fears of lockdown, isolation, and a global health crisis that few have fully processed.
In a letter addressed to the people of Tenerife, World Health Organization Director-General Tedros Adhanom Ghebreyesus acknowledged this psychological weight. “I know that when you hear the word ‘outbreak’ and watch a ship sail toward your shores, memories surface that none of us have fully put to rest,” Tedros wrote, attempting to steady a community anxious about the 147 passengers and crew members awaiting repatriation to Germany, France, and Australia.
The alarm was sparked by a cluster of hantavirus cases aboard the vessel, which resulted in three deaths and several infections between April and May. However, public health experts are quick to emphasize that while the word “outbreak” is frightening, the biological reality of hantavirus—specifically the Andes virus variant found on the Hondius—is fundamentally different from the coronavirus that paralyzed the world six years ago.
The Biological Divide: Why Hantavirus is Not COVID
The primary driver of the COVID-19 pandemic was the unprecedented nature of SARS-CoV-2. In 2019, the world faced a “novel” virus; scientists did not know its transmission rate, its incubation period, or how to treat it. Hantavirus, by contrast, is a known quantity. It has been tracked and studied since 1993, and its primary manifestation, Hantavirus Pulmonary Syndrome (HPS), is well-documented in medical literature.
The most critical difference lies in how the two viruses move through a population. Coronaviruses are highly efficient at airborne transmission, spreading through respiratory droplets and aerosols over varying distances. Hantaviruses are far less opportunistic.
“Hantaviruses—including the Andes virus—are fundamentally different from coronaviruses,” Roman Wölfel, head of the Bundeswehr Institute of Microbiology, told DW. “They can be transmitted from person to person, but far less easily and only through very close contact.”
While most hantaviruses are transmitted to humans via contact with the urine, feces, or saliva of infected rodents, the Andes virus is a rare exception capable of human-to-human transmission. Even so, this transmission requires an intensity of proximity that prevents the kind of exponential, community-wide spread seen with COVID-19.
Lessons from Argentina: The Power of Basic Containment
The confidence of health officials in Tenerife is grounded in historical data. A pivotal analysis of a 2018-2019 Andes virus outbreak in Argentina, published in the New England Journal of Medicine, demonstrates that hantavirus is highly susceptible to basic public health interventions.
During that outbreak, which began at a mass gathering where 18 people were infected, officials implemented strict isolation for confirmed cases and self-quarantine for contacts. The results were immediate and stark. The median reproductive number—the average number of people one infected person passes the virus to—dropped from 2.12 to 0.96. In epidemiological terms, any number below 1.0 means the outbreak is shrinking rather than growing.
This rapid decline suggests that the “tools of the trade”—social distancing and isolation—are even more effective against hantavirus than they were against the early strains of COVID-19. Because the virus lacks the ability to linger in the air or spread casually in a supermarket or office, targeted containment can effectively extinguish a cluster before it becomes a crisis.
| Feature | SARS-CoV-2 (COVID-19) | Andes Hantavirus |
|---|---|---|
| Transmission | Airborne/Droplets (High efficiency) | Close contact (Low efficiency) |
| Discovery | Novel (First identified 2019) | Known since 1993 |
| Pandemic Potential | Very High | Very Low |
| Control Method | Mass vaccination/Global masking | Targeted isolation/Close contact tracing |
| Primary Risk | Global community spread | Localized clusters/Zoonotic spillover |
The Timeline of the MV Hondius Outbreak
Despite the virus’s limited spread, the situation on the MV Hondius raised questions about the speed of corporate and medical response. A gap of several weeks between the first fatality and the official confirmation of the virus created a window of uncertainty that fueled public anxiety.
- April 11: The first passenger dies on board.
- May 2: The WHO is notified of a “cluster” of infected individuals on the ship.
- May 4: Oceanwide Expeditions confirms hantavirus as the cause of death, more than three weeks after the initial fatality.
- May 9: The ship docks at Tenerife’s Granadilla Port under strict health protocols.
Once the ship docked, the response shifted to a high-containment model. Spanish health authorities utilized FFP2 masks and personal protective suits, and all personal effects were transported in sealed bags. Giulia Gallo, a researcher at The Pirbright Institute in the UK, noted that these measures are fully supported by the known behavior of the virus. “Reducing any potential contacts… [is] supported by what we know about this virus,” Gallo said.
Assessing the Global Risk
For those wondering if this represents the “next pandemic,” the consensus among microbiologists is a resounding no. The Andes virus does not possess the biological machinery required to trigger a global event similar to influenza or SARS. In 2025, the WHO documented 229 cases and 59 deaths in the Americas—numbers that, while tragic for the affected families, remain statistically marginal on a global scale.
The lack of a vaccine for hantavirus is a clinical gap, but experts argue it is not a systemic vulnerability. Because the virus is so difficult to transmit between humans, the primary defense remains vigilance regarding rodent exposure and the rapid isolation of suspected human-to-human clusters.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a healthcare professional or official public health guidelines for medical concerns.
The next phase of the response involves the coordinated monitoring of the 147 repatriated individuals as they return to Germany, France, and Australia. Health ministries in those nations are expected to provide updated surveillance reports over the coming weeks to confirm that no secondary transmissions occurred during the transport process.
Do you think public health communication has improved since 2020? Share your thoughts in the comments or share this story with your network.
